AMGN vs CUBE · P/E 24, rev $36.75B vs P/E 25, rev $1.07B
Amgen Inc (AMGN) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the AMGN and CUBE stock pages for the full models.
Not investment advice.